Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium.
Abstract
The luminal and basal epithelial cells in the human mammary gland can be distinguished in tissue sections on the basis of the pattern of keratins they express. Moreover, the invasive cells in primary carcinomas show a keratin profile that corresponds to that of the dominant luminal cell (7, 8, 18, 19). When homogeneous populations of luminal epithelial cells from milk or from breast cancer metastases are cultured the profile of keratin expression seen in vivo is maintained. We have therefore used monospecific antibodies reactive with individual keratins to examine the phenotype of cells cultured in three different media from reduction mammoplasty tissue that contains both luminal and basal cells. The phenotype of cells cultured from primary breast cancers in one of these media (MCDB170) has also been examined. In characterizing cell phenotypes, antibodies to a polymorphic epithelial mucin (PEM) expressed in vivo by luminal cells, and to smooth muscle (a) actin, expressed in vivo by basal cells, have also been used. Our results show that proliferation of different cell phenotypes is selected for in different media. In milk mix (MX) developed for growth of luminal cells from milk, only the luminal cell phenotype proliferates (for only 1 or 2 passages). In medium MCDB 170, which was developed for long-term growth of human mammary epithelial cells from reduction mammoplasty organoids, cells from the basal layer proliferate, while in MM medium the basal phenotype dominates, but a few cells with the luminal phenotype are found. Around passage 3, in medium MCDB 170, most cells senesce and a subpopulation of cells proliferates on further passage. These cells retain expression of the basal epithelial keratins but also express some features characteristic of luminal epithelial cells, suggesting that the basal layer may contain a stem cell that can develop along the luminal lineage. In culture, however, they do not express keratin 19, which in vivo is a feature of the fully differentiated luminal cell. The cells cultured from primary breast cancer in medium MCDB 170 have a similar keratin profile to that of the normal cells cultured in this medium. They do not express keratin 19, even though the invasive cells in primary cancers homogeneously express this keratin in vivo. The invasive phenotype, which in its keratin profile corresponds to the differentiated luminal cell and that of the metastatic cancer lines, cannot be cultured from primary breast cancers using MX, which supports proliferation of the corresponding normal cell.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 4 | |
| 해부 | mammary
|
유방 | dict | 3 | |
| 시술 | reduction mammoplasty
|
유방성형술 | dict | 2 | |
| 해부 | basal epithelial cells
|
scispacy | 1 | ||
| 해부 | cells
|
scispacy | 1 | ||
| 해부 | luminal cell
|
scispacy | 1 | ||
| 해부 | luminal epithelial cells
|
scispacy | 1 | ||
| 해부 | milk
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | basal cells
|
scispacy | 1 | ||
| 해부 | cell
|
scispacy | 1 | ||
| 해부 | luminal cells
|
scispacy | 1 | ||
| 해부 | smooth muscle
|
scispacy | 1 | ||
| 해부 | organoids
|
scispacy | 1 | ||
| 해부 | basal layer proliferate
|
scispacy | 1 | ||
| 해부 | basal epithelial keratins
|
scispacy | 1 | ||
| 해부 | basal layer
|
scispacy | 1 | ||
| 해부 | stem cell
|
scispacy | 1 | ||
| 해부 | luminal
|
scispacy | 1 | ||
| 해부 | cancer lines
|
scispacy | 1 | ||
| 약물 | luminal
|
C0524462
Luminal region
|
scispacy | 1 | |
| 약물 | MM medium the basal phenotype
|
scispacy | 1 | ||
| 질환 | primary carcinomas
|
scispacy | 1 | ||
| 질환 | breast cancer
|
C0006142
Malignant neoplasm of breast
|
scispacy | 1 | |
| 질환 | primary breast cancers
|
scispacy | 1 | ||
| 질환 | primary breast cancer
|
scispacy | 1 | ||
| 질환 | cancers
|
C0006826
Malignant Neoplasms
|
scispacy | 1 | |
| 질환 | cancer
|
C0006826
Malignant Neoplasms
|
scispacy | 1 | |
| 질환 | malignant tissue
|
scispacy | 1 | ||
| 질환 | tissue sections
|
scispacy | 1 | ||
| 질환 | carcinomas
|
scispacy | 1 | ||
| 질환 | breast cancers
|
scispacy | 1 | ||
| 질환 | PEM
→ polymorphic epithelial mucin
|
scispacy | 1 | ||
| 질환 | cancers homogeneously
|
scispacy | 1 | ||
| 기타 | Keratin
|
scispacy | 1 | ||
| 기타 | human mammary epithelial cells
|
scispacy | 1 | ||
| 기타 | human mammary gland
|
scispacy | 1 | ||
| 기타 | keratins
|
scispacy | 1 |
MeSH Terms
Breast; Breast Neoplasms; Cells, Cultured; Cholera Toxin; Culture Media; Cyclic AMP; Epithelium; Female; Histocytochemistry; Humans; Keratins; Phenotype; Tumor Cells, Cultured
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.